Iran Daru (XTEH:IRDR1) Asset Impairment Charge : IRR0.00 Mil (TTM As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Asset Impairment Charge?

Iran Daru's Asset Impairment Charge for the six months ended in . 20 was IRR0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was IRR0.00 Mil.

Iran Daru Asset Impairment Charge Historical Data

The historical data trend for Iran Daru's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Asset Impairment Charge Chart

Iran Daru Annual Data

Trend

Asset Impairment Charge

Iran Daru Semi-Annual Data

Asset Impairment Charge

Iran Daru Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was IRR0.00 Mil.

Iran Daru Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Iran Daru's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Iran Daru (XTEH:IRDR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111

Website

https://www.irandaru.com

Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines